Praluent and Infection - a phase IV clinical study of FDA data

Summary:

Infection is reported as a side effect among people who take Praluent (alirocumab), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Norco, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Infection when taking Praluent. It is created by eHealthMe based on reports of 24,843 people who have side effects when taking Praluent from the FDA, and is updated regularly.

What is Praluent?

Praluent has active ingredients of alirocumab. It is often used in high blood cholesterol. eHealthMe is studying from 24,963 Praluent users. Check the latest studies of Praluent.

What is Infection?

Infection is found to be associated with 2,499 drugs and 2,595 conditions by eHealthMe. Check the latest studies of Infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 23, 2026

24,843 people reported to have side effects when taking Praluent.
Among them, 56 people (0.23%) have Infection.

Among these 56 people:

How long have people been on Praluent when they have Infection? *

What is the gender of people who have Infection when taking Praluent? *

female: 69.57 %
male: 30.43 %

What is the age of people who have Infection when taking Praluent? *

What are other drugs people take besides Praluent? *

What are other side effects people have besides Infection? *

Urinary Tract Infection: 6 people, 10.71%
Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 8.93%
Fall: 5 people, 8.93%
Diarrhea: 5 people, 8.93%
Injection Site Bruising: 4 people, 7.14%
Hospitalisation: 4 people, 7.14%
Muscle Aches (muscle pain): 4 people, 7.14%
Asthma: 3 people, 5.36%
Constipation: 3 people, 5.36%
Pain In Extremity: 3 people, 5.36%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 14.29%
Primary Immunodeficiency Syndrome: 3 people, 5.36%
Ovarian Cancer (cancer of ovary): 2 people, 3.57%
Drug Intolerance (drug sensitivity): 2 people, 3.57%
Stress And Anxiety: 1 person, 1.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.79%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 1.79%
Infarction (obstruction of the blood supply to an organ or region of tissue): 1 person, 1.79%
Hypocholesterolaemia (presence of abnormally small amounts of cholesterol in the circulating blood): 1 person, 1.79%
High Blood Pressure: 1 person, 1.79%

* Approximation only. Some reports may have incomplete information.

Do you take Praluent and have Infection?

- Check whether Infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Praluent:

Praluent (24,963 reports)

Infection treatments and more:

Infection (201,698 reports)

Browse all side effects of Praluent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infection:

Infection (2,499 drugs)

Browse all the conditions that are associated with Infection:

Infection (2,595 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alirocumab (the active ingredients of Praluent) and Praluent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.